Opto Circuits (India) is currently trading at Rs. 26.25, up by 1.05 points or 4.17 % from its previous closing of Rs. 25.20 on the BSE.
The scrip opened at Rs. 25.15 and has touched a high and low of Rs. 26.75 and Rs. 24.95 respectively. So far 776744 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 65.85 on 03-Apr-2013 and a 52 week low of Rs. 17.80 on 25-Jun-2013.
Last one week high and low of the scrip stood at Rs. 30.85 and Rs. 24.35 respectively. The current market cap of the company is Rs. 636.09 crore.
The promoters holding in the company stood at 28.22 % while Institutions and Non-Institutions held 30.05 % and 41.74 % respectively.
Cardiac Science Corporation, a group company of Opto Circuits (India) has received 510(k) Market clearance for the Powerheart G5 AED from U.S. FDA (Food and Drug Administration), allowing the company to begin selling the AED later this year along with its successful Powerheart G3 product line.
The Powerheart family of AEDs is designed to enable rescuers to swiftly provide effective, life-saving therapy to aid a person who has suffered sudden cardiac arrest (SCA), a condition in which the heart suddenly stops beating due to irregularities in its electrical system. The condition strikes as many as 360,000 Americans annually with the majority of cases being fatal, according to the American Heart Association.
However, the American Heart Association notes that at least 20,000 lives could be saved annually by prompt use of AEDs. Ultimately, with broad deployment of AEDs among trained responders, as many as 50,000 deaths due to SCA could be prevented each year-a cause Cardiac Science is firmly behind.
The Powerheart G5 will be available for purchase in the United States later this year.
Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.
| Company Name | CMP |
|---|---|
| Poly Medicure | 2581.85 |
| Hemant Surgical Inds | 136.50 |
| Nureca Ltd. | 273.50 |
| Prevest Denpro | 540.00 |
| Centenial Surgical | 125.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
Become a savvy and confident
stock investor.
Don't miss out! First 10 users today get it FREE
Download APP
